Jun 25, 2020 / 12:30PM GMT
Operator
Hello, ladies and gentlemen, and welcome to the Autolus Therapeutics AACR II Virtual Meeting Data Update. As a reminder, this conference call is being recorded.
I would now like to turn the conference over to your host, Dr. Lucinda Crabtree, Vice President, Head of Investor Relations. Please go ahead.
Lucinda Crabtree - Autolus Therapeutics plc - VP of IR & Corporate Communications
Thank you, Jill. Turning to Slide 2. Good morning or good afternoon, everyone, and thank you for taking part in today's call on the AACR II Virtual Meeting Data Update. I am Lucinda Crabtree, Vice President and Head of Investor Relations.
With me today are Dr. Christian Itin, our Chairman and Chief Executive Officer; Dr. Martin Pulé, our Founder and Chief Scientific Officer; Dr. Vijay Reddy, our Chief Medical Officer; Dr. Muhammad Al-Hajj, our Head of Translational Medicine; Dr. Marco Della Peruta, a senior scientist in the immunobiology department of our R&D team; Dr. Mathieu Ferrari, an Associate Director of Binders Discovery and our R&D team.
Autolus Therapeutics plc - Special Call Transcript
Jun 25, 2020
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers